# Zhejiang Jingxin Pharmaceutical Co., Ltd. – FDA Inspection, Oct 17, 2025

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-jingxin-pharmaceutical-co-ltd/57dddb9e-134f-4ff1-8630-0b0f65b6729e
Source feed: FDA_Inspections

> FDA inspection 1290202 of Zhejiang Jingxin Pharmaceutical Co., Ltd., October 17, 2025. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1290202
- Company Name: Zhejiang Jingxin Pharmaceutical Co., Ltd.
- Inspection Date: 2025-10-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 2

## Related Documents

- FDA Inspection 1243909 - 2024-06-21
- [FDA Inspection 1074667 - 2018-11-09](https://www.keypedia.com/records/fda_inspections/zhejiang-jingxin-pharmaceutical-co-ltd/ad1118c1-ef12-4812-aefb-0d7f8ef6bbb2)

## Related Officers

- [Carolina D. Vasquez](https://www.keypedia.com/people/carolina-d-vasquez/ffa9d542-e660-4575-831e-f11a2de4b978)

Company: https://www.keypedia.com/companies/zhejiang-jingxin-pharmaceutical-co-ltd/ab00cf21-af67-4184-bd55-ffdc1105b98a

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8